Pharma & Bio
Business·Industry
Outcomes of Some M&A Deals Remain Uncertain… Future Investment Performance to Be Watched Closely [PharmaResearch Deep Seek ③]
PharmaResearch(214450)is accelerating its mergers and acquisitions (M&A) and overseas business expansion, leveraging its strong earnings growth. Although some subsidiaries continue to post losses and …
Technology
“My Cat Will Live to Be 30?”… The Truth Behind the Buzz Surrounding a New Japanese Drug
(Graphic: ChatGPT)
A treatment for chronic kidney disease (CKD) that is said to extend a cat’s lifespan by up to 30 years is generating buzz, particularly on social media. This is due to “FeliAIM,…
Technology
Cellid Surges on COVID Fears; VUNO Plunges on Rights Offering [K-Bio Pulse]
South Korean biotech and healthcare stocks showed sharply divergent performance on Aug. 31. Cellid Co., Ltd. surged 27% amid renewed concerns over COVID-19, Onconic Therapeutics Inc. jumped 22% follow…
Technology
Cellid Co., Ltd. 'Smiles' Amid COVID-19 Resurgence… VUNO, Inc. 'Plummets' on Rights Offering Shock [Bio Spotlight]
On the 31st, stock prices in the biotech and healthcare sector showed mixed results depending on individual news. Cellid Co., Ltd.(299660)saw its stock price surge 27% amid concerns over a resurgence …
Technology
YuyuPharma’s ‘Bonki-ju’ Heads to Canada… Urgently Deployed to Address Local Supply Shortage
(Graphic: ChatGPT)
As the supply shortage of calcitriol injections—used to treat patients with chronic kidney disease in Canada—persists, “Bonki-ju” from YuyuPharma(000220)is expected to be introdu…
Technology
Olix Pharmaceuticals, Inc. Splits Its Business by ‘Hierarchy’ Rather Than by Target… RNAi Technology Export Model Changes
Lee Dong-ki, CEO of Olix Pharmaceuticals, Inc. (Photo courtesy of Olix Pharmaceuticals, Inc.)
“This is a new type of contract that is rare in the industry.”This is what an industry insider said re…
Lifestyle
ORIENTBIO Highlights Primate CRO… Cites “Trade Secrets” Regarding Core Business Information
ORIENTBIO(002630) Doubts are growing regarding the company’s capabilities to conduct non-clinical trials (CRO) involving non-human primates.The company has repeatedly emphasized its proprietary primat…
Technology
Alteogen Inc., Now a Commercial Biotech Firm: Will It Secure Its Fourth Technology Export Deal This Year?
Panoramic view of Alteogen Inc.’s headquarters and research center (Photo courtesy of Alteogen Inc.)
Alteogen Inc.(196170)is being recognized as a global platform company that has moved beyond the…
Technology
‘3D Direct Printing’ Catches the Eye of Invisalign… Graphy Inc. Bets on Shape Memory [BIO: A Battle of Titans]
The technological competition between Align Technology, the undisputed leader in the global clear aligner market, and Graphy Inc., the South Korean company, is entering an intriguing phase. This comes…
Technology
Cho Nam-hoon, President of MTS: “AI Can Predict a Patient’s Future—Something Even 30 Years of Pathology Experience Couldn’t Do”
“I’ve been a pathologist for over 30 years, but I was never able to predict a patient’s future based solely on a slide. Even though I could tell how severe the disease was, I didn’t know what would ha…